Ora­sis gains FDA ap­proval for pres­by­opia eye drops, fol­low­ing in Ab­b­Vie’s foot­steps

Ora­sis Phar­ma­ceu­ti­cals has se­cured ap­proval in the US for its age-re­lat­ed blur­ry vi­sion eye drops, mark­ing the sec­ond time the FDA has green­lit a pres­by­opia …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER